References
- Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem 2006;13:87–98
- Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493–506
- Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci 2002;957:210–29
- Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218–20
- Hrenn A, Steinbrecher T, Labahn A, et al. Plant phenolics inhibit neutrophil elastase. Planta Med 2006;72:1127–31
- Chan MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 2002;63:99–104
- Docherty JJ, Fu MM, Hah JM, et al. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Res 2005;67:155–62
- Khanna S, Venojarvi M, Roy S, et al. Dermal wound healing properties of redox-active grape seed proanthocyanidins. Free Radic Biol Med 2002;33:1089–96
- Fabbrocini G, Staibano S, De Rosa G, et al. Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am J Clin Dermatol 2011;12:133–41
- Hung CF, Lin YK, Huang ZR, Fang JY. Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol Pharm Bull 2008;31:955–62
- Rasheed A. Cyclodextrins as drug carrier molecule: a review. Sci Pharm 2008;76:567–98
- Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem 2004;39:1033–46
- Szejtli J. Cyclodextrin technology. Netherlands: Kluwer; 1988:1–464
- Szejtli J, Osa T. Comprehensive supramolecular chemistry, vol. 3: cyclodextrins. Oxford: Pergamon; 1996
- Chiou WL, Riegelman S. Increased dissolution rates of water-insoluble cardiac glycosides and steroids via solid dispersions in polyethylene glycol 6000. J Pharm Sci 1971;60:1569–71
- Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
- Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients, 4th ed. London–Washington: Press and American Pharmacists Association; 2003:454–9
- Fan E, Zhang K, Jiang S, et al. Analysis of trans-resveratrol in grapes by micro-high performance liquid chromatography. Anal Sci 2008;24:1019–23
- De Stefano D, Maiuri MC, Simeon V, et al. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur J Pharmacol 2007;566:192–99
- De Stefano D, Tommonaro G, Simeon V, et al. A Polysaccharide from tomato (Lycopersicon esculentum) peels affects NF-kappaB activation in LPS-stimulated J774 macrophages. J Nat Prod 2007;70:1636–9
- Higuchi T, Connors KA. Phase solubility techniques. In: Reilley CN, ed. Advances in analytical chemistry and instrumentation. New York: Wiley-Interscience; 1965:117–212
- Bertacche V, Lorenzi N, Nava D, et al. Host–guest interaction study of resveratrol with natural and modified cyclodextrins. J Incl Phenom Macr Chem 2006;55:279–87
- Fini A, Moyano JR, Ginés JM, et al. Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13. Eur J Pharm Biopharm 2005;60:99–111
- Jagdeo J, Adams L, Lev-Tov H, et al. Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro. J Drugs Dermatol 2010;9:1523–6
- Kristl J, Teskac K, Caddeo C, et al. Improvements of cellular stress response on resveratrol in liposomes. Eur J Pharm Biopharm 2009;73:253–9
- Lucas-Abellán C, Mercader-Ros MT, Zafrilla MP, et al. ORAC-fluorescein assay to determine the oxygen radical absorbance capacity of resveratrol complexed in cyclodextrins. J Agric Food Chem 2008;56:2254–9
- Teskac K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 2010;390:61–9
- Loftsson T, Vogensen SB, Brewster ME, Konrádsdóttir F. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 2007;96:2532–46